GoHealth Balance Sheet Health

Financial Health criteria checks 4/6

GoHealth has a total shareholder equity of $455.0M and total debt of $497.7M, which brings its debt-to-equity ratio to 109.4%. Its total assets and total liabilities are $1.5B and $1.0B respectively.

Key information

109.4%

Debt to equity ratio

US$497.71m

Debt

Interest coverage ration/a
CashUS$90.81m
EquityUS$454.96m
Total liabilitiesUS$1.04b
Total assetsUS$1.50b

Recent financial health updates

Recent updates

GoHealth, Inc. (NASDAQ:GOCO) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

May 10
GoHealth, Inc. (NASDAQ:GOCO) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

GoHealth stock jumps 11% premarket on $50M private investment

Sep 26

GoHealth: Painful Competition, Cost Controls Are Key

Feb 20

GoHealth Looks To Q4 For Submission Growth

Dec 07

GoHealth: Post Sell-Off, A Fresh Look

Aug 25

GoHealth amends credit agreement, lowers the interest rate to 4%

Jun 15

GoHealth EPS misses by $0.61, misses on revenue

Nov 11

Financial Position Analysis

Short Term Liabilities: GOCO's short term assets ($476.4M) exceed its short term liabilities ($370.0M).

Long Term Liabilities: GOCO's short term assets ($476.4M) do not cover its long term liabilities ($674.6M).


Debt to Equity History and Analysis

Debt Level: GOCO's net debt to equity ratio (89.4%) is considered high.

Reducing Debt: GOCO had negative shareholder equity 5 years ago, but is now positive and has therefore improved.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable GOCO has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: GOCO is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 5.2% per year.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.